Concepedia

Risk of cancer, cardiovascular disease, thromboembolism, and mortality in patients with rheumatoid arthritis receiving Janus kinase inhibitors: a real-world retrospective observational study using Korean health insurance data

Hong Ki Min, Hyeongsu Kim, Ho Jin Jeong, Se Hee Kim, Hae‐Rim Kim, Sang‐Heon Lee, Kun-Sei Lee, Soon‐Ae Shin, Jong Heon Park

Epidemiology and Health · 2023 · 22 citations · 26 references

DOIFull text

Open access

Abstract

In this study, JAKis did not increase the risk of AMI, stroke, CV-related mortality, MACE, VTE, ATE, or cancer in Korean RA patients relative to TNFis.

References

26

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update

Josef S Smolen, Robert Landewé, J. W. J. Bijlsma et al. · Annals of the Rheumatic Diseases · 2020 · 2.6K citations · Full text

Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis

Steven R. Ytterberg, Deepak L. Bhatt, Ted R. Mikuls et al. · New England Journal of Medicine · 2022 · 1.5K citations · Full text

Data Resource Profile: The National Health Information Database of the National Health Insurance Service in South Korea

Sang Cheol Seong, Yeon-Yong Kim, Young‐Ho Khang et al. · International Journal of Epidemiology · 2016 · 1.3K citations · Full text

, , +21

Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout

William B. White, Kenneth G. Saag, Michael A. Becker et al. · New England Journal of Medicine · 2018 · 860 citations · Full text

Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis

Jeffrey D. Greenberg, Joel M. Kremer, Jeffrey R. Curtis et al. · Annals of the Rheumatic Diseases · 2010 · 348 citations · Full text